Abstract
Ethylmalonic encephalopathy (EE) is an autosomal recessive devastating metabolic disorder affecting the brain, gastrointestinal tract, peripheral vessels and rarely the other vascular organs. We report a 10-month-old girl who presented as a meningococcemia clinic but later diagnosed ethylmalonic encephalopathy. Molecular analyses revealed a homozygous c.554 T > G; p. L185R mutation in ETHE1 gene. She was only partially benefited from riboflavine, coenzyme Q10, metronidazole, N-acetylcysteine and symptomatic treatment and discharged from hospital with the sequela of oxygene dependance and developmental delay. We observed N-acetylcysteine 100 mg/kg/day intravenous infusion theraphy may be the most important drug especially in comatous EE patients.
References
Burlina A, Zacchello F, Dionisi-Vici C et al (1991) New clinical phenotype of branched-chain acyl-CoA oxidation defect. Lancet 338:1522–1523
Di Rocco M, Caruso U, Briem E et al (2006) A case of ethylmalonic encephalopathy with atypical clinical and biochemical presentation. Mol Genet Metab 89:395–397
Dionisi-Vici C, Diodato D, Torre G et al (2016) Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease. Brain 139:1045–1051
Drousiotou A, DiMeo I, Mineri R, Georgiou T, Stylianidou G, Tiranti V (2011) Ethylmalonic encephalopathy: application of improved biochemical and molecular diagnostic approaches. Clin Genet 79:385–390
Dweikat I, Naser E, Damsah N, Libdeh BA, Bakri I (2012) Ethylmalonic encephalopathy associated with crescentic glomerulonephritis. Metab Brain Dis 27:613–616
Garcia-Silva MT, Ribes A, Campos Y, Garavaglia B, Arenas J (1997) Syndrome of encephalopathy, petechiae, and ethylmalonic aciduria. Pediatr Neurol 17:165–170
Giordano C, Viscomi C, Orlandi M et al (2012) Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy. J Inherit Metab Dis 35:451–458
Grosso S, Mostardini R, Farnetani MA et al (2002) Ethylmalonic encephalopathy: further clinical and neuroradiological characterization. J Neurol 249:1446–1450
Jamroz E, Paprocka J, Adamek D et al (2011) Clinical and neuropathological picture of ethylmalonic aciduria - diagnostic dilemma. Folia Neuropathol 49:71–77
Mineri R, Rimoldi M, Burlina AB et al (2008) Identification of new mutations in the ETHE1 gene in a cohort of 14 patients presenting with ethylmalonic encephalopathy. J Med Genet 45:473–478
Nowaczyk MJ, Blaser SI, Clarke JT (1998) Central nervous system malformations in ethylmalonic encephalopathy. Am J Med Genet 75:292–296
Ozand PT, Rashed M, Millington DS et al (1994) Ethylmalonic aciduria: an organic acidemia with CNS involvement and vasculopathy. Brain Dev 16:12–22
Papetti L, Garone G, Schettini L et al (2015) Severe early onset ethylmalonic encephalopathy with west syndrome. Metab Brain Dis 30:1537–1545
Pavlou E, Augoustides-Savvopoulou P, Gregersen N, Haas D, Gkampeta A, Athanassiadou-Piperopoulou F (2013) An infant with ethylmalonic encephalopathy masquerading as a hematologic disorder. J Child Neurol 28:668–671
Pigeon N, Campeau PM, Cyr D, Lemieux B, Clarke JT (2009) Clinical heterogeneity in ethylmalonic encephalopathy. J Child Neurol 24:991–996
Tiranti V, Zeviani M (2013) Altered sulfide (H(2)S) metabolism in ethylmalonic encephalopathy. Cold Spring Harb Perspect Biol 5:a011437. doi:10.1101/cshperspect.a011437
Tiranti V, D'Adamo P, Briem E et al (2004) Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74:239–252
Tiranti V, Briem E, Lamantea E et al (2006) ETHE1 mutations are specific to ethylmalonic encephalopathy. J Med Genet 43:340–346
Tiranti V, Viscomi C, Hildebrandt T et al (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15:200–205
Viscomi C, Burlina AB, Dweikat I et al (2010) Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. Nat Med 16:869–871
Yiş U, Polat İ, Karakaya P, Ayanoğlu M, Hiz AS (2015) Importance of acrocyanosis in delayed walking. J Pediatr Neurosci 10:80–81
Zafeiriou DI, Augoustides-Savvopoulou P, Haas D et al (2007) Ethylmalonic encephalopathy: clinical and biochemical observations. Neuropediatrics 38:78–82
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kılıç, M., Dedeoğlu, Ö., Göçmen, R. et al. Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine. Metab Brain Dis 32, 293–296 (2017). https://doi.org/10.1007/s11011-016-9928-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-016-9928-5